Aileron Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Rein Therapeutics

04/05/2024 03:09

* Aileron Therapeutics Inc  ALRN.OQ   ALRN.O  is expected
to report results on May 6 (estimated) for the period ending
March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Aileron Therapeutics Inc
is
for a loss of 14 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aileron
Therapeutics Inc is $19.00​, above​ its last closing price
of $3.76. ​​​

This summary was machine generated May 4 at 02:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)